寿仙谷关联交易预案披露，主力资金连续流出

Group 1 - The company disclosed a related party transaction plan for 2026, involving the procurement of goods worth 20 million yuan and sales of goods worth 6.2 million yuan, which requires shareholder approval and may impact operations [2] - The company is not currently investing in short videos or short dramas but is promoting its brand through platforms like Douyin and WeChat, while its parent company is involved in the film "Unbreakable" [3] - The company has experienced continuous net outflows of main funds since early January 2026, potentially due to market style rotation and short-term pressure on the traditional Chinese medicine sector [4] Group 2 - The company is expanding its market presence outside Zhejiang Province, focusing on fast-moving consumer goods development and digital empowerment as part of its long-term strategy [5] - The traditional Chinese medicine industry is driven by aging demographics and policy support, but there are risks associated with deepening centralized procurement policies and fluctuations in raw material costs [6]